| Name
|
Dermorphin
|
| Code
|
|
| The alias
|
Dermorphin
|
| Sequence (single letter abbreviation)
|
Y-DAla-FGYPS-NH2
|
| Sequence (three-letter abbreviation)
|
H-Tyr-DAla-Phe-Gly-Tyr-Pro-Ser-NH2?(trifluoroacetate salt)
|
| A basic description
|
Highly selective μ-opioid receptor agonist that can be applied in basic opioid pharmacology and in studying specifically peripheral μ-receptor interactions as its polar character plays a role in blocking the blood-brain barrier to a significant extent.
|
| solubility
|
|
| The molecular weight
|
802.9
|
| Chemical formula
|
C40H50N8O10
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
P.C. Montecucchi et al., Int. J. Peptide Protein Res., 17, 275 (1981)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|